All Articles
Artificial Intelligence

Firefly Neuroscience Debuts On Nasdaq

August 13, 2024
x min read
Firefly Neuroscience Debuts On Nasdaq

There’s a new neuroscience company on the Nasdaq. And they’re aiming to change the future of brain health through artificial intelligence.

What’s happening:

  • Firefly Neuroscience (NASDAQ: AIFF) has raised an additional $3.5M USD in funding and officially begun trading on the Nasdaq

Why it matters:

By the numbers:

  • $60M USD of venture capital funding has gone into developing Firefly’s technology platform since inception
  • Firefly has successfully completed 77,000 brain scans on 17,000 individual patients

Going deeper:

  • Firefly’s artificial intelligence technology platform Brain Network Analytics was previously cleared by the FDA and provides unparalleled insight into brain imaging which can enable more precise diagnoses and potential treatment options for individuals dealing with dementia and mental health conditions

Discover the world's most disruptive early stage companies with 35,000+ investors.

The markets and trends that matter, made simple.

Join top talent at the world's most respected institutions, companies, and venture capital funds.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.